# OnCo record myriad-ruling (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/myriad-ruling/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "myriad-ruling" ;
  schema:name "Association for Molecular Pathology v. Myriad Genetics (2013)"@en ;
  schema:alternateName "Myriad ruling"@en, "Myriad decision"@en, "Myriad case"@en, "AMP v. Myriad"@en, "gene patents"@en, "gene patent"@en, "gene patenting"@en, "BRCA patents"@en, "BRCA gene patents"@en ;
  schema:description "The 2013 US Supreme Court ruling that human genes as they occur in nature cannot be patented, which ended one company's monopoly on BRCA testing and let hereditary cancer testing become cheap and widely available."@en ;
  schema:url <https://onco.cc/terms/myriad-ruling/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics,_Inc.> ;
  schema:citation <https://en.wikipedia.org/wiki/Association_for_Molecular_Pathology_v._Myriad_Genetics,_Inc.>, <https://www.oyez.org/cases/2012/12-398> ;
  onco:tag "law", "us" ;
  onco:related <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/terms/gbrca-mutation/>, <https://onco.cc/terms/gina/>, <https://onco.cc/terms/hipaa/>, <https://onco.cc/terms/companion-diagnostic-term/>, <https://onco.cc/terms/fda-ldt-rule/>, <https://onco.cc/terms/trips-doha/>, <https://onco.cc/terms/nexavar-compulsory-licence/> ;
  onco:companies <https://onco.cc/companies/myriad-genetics/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-hereditary-risk/>, <https://onco.cc/bottlenecks/b-ip-collaboration/>, <https://onco.cc/bottlenecks/b-data-silos/> .